AstraZeneca (AZN) RNS Announcements
Add to Alert list| Date | Time | Source | Announcement |
|---|---|---|---|
| 31 Mar 2005 | 10:30 AM | Director Shareholding | |
| 29 Mar 2005 | 04:16 PM | Director Shareholding | |
| 29 Mar 2005 | 04:15 PM | Director Shareholding | |
| 23 Mar 2005 | 02:00 PM | Notice of AGM | |
| 21 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 18 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 17 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 15 Mar 2005 | 12:00 PM | Director Shareholding | |
| 14 Mar 2005 | 02:00 PM | Directorate Change | |
| 14 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 10 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 08 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 03 Mar 2005 | 04:00 PM | Holding(s) in Company | |
| 03 Mar 2005 | 04:00 PM | Holding(s) in Company | |
| 02 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 01 Mar 2005 | 04:00 PM | Director Shareholding | |
| 28 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 25 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 24 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 23 Feb 2005 | 01:30 PM | Regulatory Approval | |
| 22 Feb 2005 | 11:08 AM | Annual Report and Accounts | |
| 21 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 15 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 14 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 11 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 10 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 07 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 04 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 02 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 27 Jan 2005 | 11:00 AM | Final Results - Part 3 of 3 | |
| 27 Jan 2005 | 11:00 AM | Final Results - part 2 of 3 | |
| 27 Jan 2005 | 11:00 AM | Final Results - part 1 of 3 | |
| 26 Jan 2005 | 04:00 PM | Holding(s) in Company | |
| 26 Jan 2005 | 09:00 AM | Notice of Results | |
| 19 Jan 2005 | 02:30 PM | Statement re Exanta | |
| 17 Jan 2005 | 04:00 PM | Holding(s) in Company | |
| 17 Jan 2005 | 10:30 AM | Director Shareholding | |
| 04 Jan 2005 | 03:30 PM | Capital Group | |
| 04 Jan 2005 | 02:46 PM | Iressa | |
| 31 Dec 2004 | 07:00 AM | Transaction in Own Shares | |
| 30 Dec 2004 | 07:00 AM | Transaction in Own Shares | |
| 29 Dec 2004 | 07:00 AM | Crestor Japan | |
| 24 Dec 2004 | 11:00 AM | Capital Group | |
| 24 Dec 2004 | 07:00 AM | Transaction in Own Shares | |
| 20 Dec 2004 | 07:00 AM | Transaction in Own Shares | |
| 17 Dec 2004 | 11:07 AM | R&D Guidance Note | |
| 17 Dec 2004 | 11:02 AM | Directorate Change | |
| 17 Dec 2004 | 11:00 AM | Iressa | |
| 15 Dec 2004 | 07:00 AM | Transaction in Own Shares | |
| 13 Dec 2004 | 07:00 AM | Transaction in Own Shares |
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
Latest directors dealings
- 2 days ago Premier Miton Group
- 2 days ago YouGov
- 2 days ago K3 Business Technology Group
- 2 days ago Foresight Group Holdings Limited NPV
- 2 days ago Investec